Differentiation of Monocytic Cellsis Accompanied by a Change in the Expression of the Set of Oct-1 Isoforms

 
PIIS086956520003422-7-1
DOI10.31857/S086956520003422-7
Publication type Article
Status Published
Authors
Affiliation:
Affiliation:
Affiliation:
Affiliation:
Affiliation:
Affiliation:
Journal nameDoklady Akademii nauk
EditionVolume 483 Issue 1
Pages105-107
Abstract

  

Keywords
Received14.12.2018
Publication date14.12.2018
Cite   Download pdf To download PDF you should sign in
Размещенный ниже текст является ознакомительной версией и может не соответствовать печатной

views: 1148

Readers community rating: votes 0

1. Sturm R.A., Das G., Herr W. The Ubiquitous Octamer-Binding Protein Oct-1 Contains a POU Domain with a Homeo Box Subdomain // Genes DeveloV. 1988. V. 2. P. 1582–1599.

2. Pankratova E.V., Stepchenko A.G., Portseva T., Mogila V.A., Georgieva S.G. Different N-Terminal Isoforms of Oct-1 Control Expression of Distinct Sets of Genes and Their High Levels in Namalwa Burkitt’s Lymphoma Cells Affect a Wide Range of Cellular Processes // Nucleic Acids Res. 2016. V. 44. P. 9218–9230.

3. Falkner F.G., Zachau H.G. Correct Transcription of an Immunoglobulin Kappa Gene Requires an Upstream Fragment Containing Conserved Sequence Elements // Nature. 1984. V. 310. № 5972. P. 71–74.

4. Stepchenko A.G. The nucleotide sequence of mouse OCT-1 cDNA // Nucl. Acids Res. 1992. V. 20. № 6. P. 1419.

5. Krylova I.D., Portseva T.N., Georgieva S.G., Stepchenko A.G., Pankratova E.V. Novaya izoforma mRNK faktora transkriptsii Oct-1 transkribiruetsya s al'ternativnogo promotora // Molekulyar. biologiya. 2013. T. 47. № 4. S. 552–558.

6. Portseva T.N., Krylova I.D., Georgieva S.G., Stepchenko A.G., Pankratova E.V. Novyj al'ternativnyj promotor v regulyatsii transkriptsii gena Oct-1 cheloveka // DAN. 2013. T. 449. № 1. S. 110–112.

7. Pankratova E.V., Deyev I.E., Zhenilo S.V., Polanovsky O.L. Tissue-Specific Isoforms of the Ubiquitous Transcription Factor Oct-1 // Mol. Genet. Genom. 2001. V. 266. № 2. P. 239–245.

8. Luchina N.N., Krivega I.V., Pankratova E.V. Human Oct-1L Isoform Has Tissue-Specific Expression Pattern Similar to Oct-2 // Immunol. Lett. 2003.V. 85. P. 237–241.

9. Stepchenko A.G., Luchina N.N., Pankratova E.V. Cysteine 50 of the POU H Domain Determines the Range of Targets Recognized by POU Proteins // Nucl. Acids Res. 1997. V. 25. P. 2847–2853.

10. Bellance N.,Pabst L.,Allen G., Rossignol R., Nagrath D. Oncosecretomics Coupled to Bioenergetics Identifies α-amino Adipic Acid, Isoleucine and GABA as Potential Biomarkers of Cancer: Differential Expression of c-Myc, Oct1 and KLF4 coordinates metabolic changes // Biochim. Biophys. et Acta. 2012. V. 1817. P. 2060–2071.

11. Metcalf D. Hematopoietic Cytokines // Blood. 2008. V. 111. P. 485–491.

12. Friedman A.D. Transcriptional Control of Granulocyte and Monocyte Development // Oncogene. 2007. V. 26. P. 6816–6828.

13. Murao S., Gemmell M.A., Callaham M.F., Anderson N.L., Huberman E. Control of Macrophage Cell Differentiation in Human Promyelocytic HL-60 Leukemia Cells by 1,25-Dihydroxyvitamin D3 and Phorbol-12-Myristate-13-acetate // Cancer Res. 1983. V. 43. P. 4989–4996.

14. Lee M.S., Son M.Y., Park J.I., Park C., Lee Y.C., Son C.B., Kim Y.S., Paik S.G., Yoon W.H., Park S.K., Hwang B.D., Lim K. Modification of Octamer Binding Transcriptional Factor is Related to H2B Histone Gene Repression During Dimethyl Sulfoxide-Dependent Differentiation of HL-60 cells // Cancer Lett. 2001. V. 172. P. 165–170.

15. Padilla P.I., Wada A., Yahiro K., Kimura M., Niidome T., Aoyagi H., Kumatori A., Anami M., Hayashi T., Fujisawa J., Saito H., Moss J., Hirayama T. Morphologic Differentiation of HL-60 Cells is Associated with Appearance of RPTPbeta and Induction of Helicobacter Pylori VacA Sensitivity // J. Biol. Chem. 2000. V. 275. P. 15200–15206.

Система Orphus

Loading...
Up